A longitudinal study evaluating the effect of exacerbations on physical activity in patients with chronic obstructive pulmonary disease

Annals of the American Thoracic Society

Volumn 10, Issue 6, 2013, Pages 559-564

  Ehsan, Mohsin ^a   Khan, Rana ^a   Wakefield, Dorothy ^b   Qureshi, Asher ^c   Murray, Lindsey ^d   ZuWallack, Richard ^a,c   Leidy, Nancy Kline ^d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c S Francis Hosp and Medical Center   (United States)

^d UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

Chronic obstructive; COPD exacerbation; Motor activity; Pulmonary disease

Indexed keywords

ACCELEROMETER; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OUTCOME VARIABLE; PHYSICAL ACTIVITY;

ACCELEROMETRY; AGED; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR ACTIVITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84892184723     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201304-100OC     Document Type: Article

References (30)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD [accessed October 2013]. Available from: www.goldcopd.com.
2. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-1138.
3. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608-1613.
4. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006;61:772-778.
5. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:972-977.
6. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140:331-342.
7. Garcia-Rio F, Rojo B, Casitas R, et al. Prognostic value of the objective measurement of daily physical activity in COPD patients.Chest 2012;142:338-346.
8. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536-544.
9. Sasaki JE, John D, Freedson PS. Validation and comparison of ActiGraph activity monitors. J Sci Med Sport 2011;14:411-416.
10. Gorzelniak L, Dias A, Schultz K, et al. Comparison of recording positions of physical activity in patients with severe COPD undergoing LTOT. COPD 2012;9:528-537.
11. . Kumar M, Normadin E, Makuch M, Bautista J, Marolda C, Medimpuda A, ZuWallack RL, Lahiri B. A study to determine the optimal site to wear an activity monitoring device in individuals with chronic obstructive pulmonary disease (COPD). Chest 2009;136 (Meeting Abstracts):57S.
12. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-222.
13. Leidy NK, Abbott RD, Fedenko KM. Sensitivity and reproducibility of the dual-mode actigraph under controlled levels of activity intensity. Nurs Res 1997;46:5-11.
14. Jones PW, Chen WH, Wilcox TK, Sethi S, Leidy NK. Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest 2011;139:1388-1394.
15. Leidy NK, Wilcox TK, Jones PW, et al. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health 2010;13:965-975.
16. Leidy NK, Wilcox TK, Jones PW, Roberts L, Powers JH, Sethi S. Standardizing measurement of chronic obstructive pulmonary disease exacerbations: reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2011;183:323-329.
17. Belza B, Steele BG, Hunziker J, et al. Correlates of physical activity in chronic obstructive pulmonary disease. Nurs Res 2001;50:195-202.
18. Xu W, Collet JP, Shapiro S, et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J 2010;35:1022-1030.
19. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
20. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008;177:396-401.
21. Borges RC, Carvalho CR. Physical activity in daily life in Brazilian COPD patients during and after exacerbation. COPD 2012;9: 596-602.
22. Spruit MA, Gosselink R, Troosters T, et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003;58:752-756.
23. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinflation in COPD. COPD 2006;3:219-232.
24. Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40: 1115-1122.
25. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180:506-512.
26. O'Donnell DE, Laveneziana P. Dyspnea and activity limitation in COPD: mechanical factors. COPD 2007;4:225-236.
27. Van Remoortel H, Raste Y, Louvaris Z, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012;7:e39198.
28. Vanhelst J, Hurdiel R, Mikulovic J, et al. Validation of the Vivago wristworn accelerometer in the assessment of physical activity. BMC Public Health 2012;12:690.
29. Bauldoff GS, Ryan-Wenger NA, Diaz PT. Wrist actigraphy validation of exercise movement in COPD. West J Nurs Res 2007;29:789-802.
30. Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, et al. Physical activity in COPD patients: patterns and bouts. Eur Respir J. 2013;42: 993-1002.